Strategic acquisitions Ottobock’s recent acquisitions of Blatchford and Matton expand B2B capabilities and complement its neuro-orthotics and prosthetics portfolio, signaling open opportunities for cross-sell of components, digitalisation solutions, and integration services.

Global growth With operations in 45 countries and a multi-market presence, Ottobock’s double-digit organic growth in B2B alongside continued B2C expansion indicates high demand for advanced mobility solutions across hospital, clinic, and direct-to-consumer channels.

R&D and patents Ottobock’s strong R&D focus, extensive patent portfolio, and ongoing product innovations such as Taleo Adapt and FES-enabled devices highlight opportunities to position advanced digital fitting, data-driven care, and future-ready prosthetics collaborations.

Financial strength Reported high revenue scale and improving profitability in H1 2026, despite FX headwinds, suggests capacity for incremental project funding, large-scale deployments, and long-term procurement partnerships with healthcare systems.

Digital ecosystem Adoption of tech stack elements like Azure, Looker, HubSpot, and Contentful, plus emphasis on digitalisation of care networks, presents cross-sell possibilities for CRM-driven patient journeys, data analytics, and remote-monitoring solutions.